Assessment of Clinical Outcomes in Patients With Fibromyalgia: Analysis From the UK Medical Cannabis Registry
https://curaleafaustralia.com/wp-content/uploads/2026/06/Brain-Behaviour-1.webp
114
150
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/Brain-Behaviour-1.webp
UK Medical Cannabis Registry: An Analysis of Clinical Outcomes of Medicinal Cannabis Therapy for Attention-deficit/hyperactivity Disorder
https://curaleafaustralia.com/wp-content/uploads/2026/06/Neuropsychopharmacology-2.webp
595
782
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/Neuropsychopharmacology-2.webp
Clinical Outcome Data of Anxiety Patients Treated With Cannabis-based Medicinal Products in the United Kingdom: A Cohort Study From the UK Medical Cannabis Registry
https://curaleafaustralia.com/wp-content/uploads/2026/06/Psychopharmacology.webp
155
204
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/Psychopharmacology.webp
An Observational Study of Clinical Outcome Measures in Patients Treated With Cannabis-based Medicinal Products on the UK Medical Cannabis Registry
https://curaleafaustralia.com/wp-content/uploads/2026/06/Neuropsychopharmacology-1.webp
595
782
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/Neuropsychopharmacology-1.webp
Comparing the Effects of Medical Cannabis for Chronic Pain Patients With and Without Co-morbid Anxiety: A Cohort Study
https://curaleafaustralia.com/wp-content/uploads/2026/06/Expert-Review-of-Neurotherapeutics-1.webp
200
261
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/Expert-Review-of-Neurotherapeutics-1.webp
A Cohort Study Comparing the Effects of Medical Cannabis for Anxiety Patients With and Without Comorbid Sleep Disturbance
https://curaleafaustralia.com/wp-content/uploads/2026/06/Neuropsychopharmacology.webp
595
782
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/Neuropsychopharmacology.webp





